This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
He H, Guzman RE, Cao D, Sierra-Marquez J, Yin F, Fahlke C, et al. The molecular and phenotypic spectrum of CLCN4-related epilepsy. Epilepsia. 2021;62(6):1401–1415.HeHGuzmanRECaoDSierra-MarquezJYinFFahlkeCThe molecular and phenotypic spectrum of CLCN4-related epilepsy202162614011415Search in Google Scholar
Xu X, Lu F, Zhang L, Li H, Du S, Tang J. Novel CLCN4 variant associated with syndromic X-linked intellectual disability in a Chinese girl: a case report. BMCPediatr. 2021;3;21(1):384.XuXLuFZhangLLiHDuSTangJNovel CLCN4 variant associated with syndromic X-linked intellectual disability in a Chinese girl: a case report20213211384Search in Google Scholar
Weinert S, Gimber N, Deuschel D, Stuhlmann T, Puchkov D, Farsi Z, et al. Uncoupling endosomal CLC chloride/proton exchange causes severe neurodegeneration. EMBO J. 2020;4;39(9):e103358.WeinertSGimberNDeuschelDStuhlmannTPuchkovDFarsiZUncoupling endosomal CLC chloride/proton exchange causes severe neurodegeneration20204399e103358Search in Google Scholar
Palmer EE, Pusch M, Picollo A, Forwood C, Nguyen MH., et al. Functional and clinical studies reveal pathophysiological complexity of CLCN4-related neurodevelopmental condition. Mol Psychiatry. 2023 Feb;28(2):668–697.PalmerEEPuschMPicolloAForwoodCNguyenMHFunctional and clinical studies reveal pathophysiological complexity of CLCN4-related neurodevelopmental condition2023Feb282668697Search in Google Scholar
Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia. 2007 Jan;48(1):43–58.BoughKJRhoJMAnticonvulsant mechanisms of the ketogenic diet2007Jan4814358Search in Google Scholar
Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina Bergqvist AG., et al. Charlie Foundation; Matthew’s Friends; Practice Committee of the Child Neurology Society. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018 May 21;3(2):175–192.KossoffEHZupec-KaniaBAAuvinSBallaban-GilKRChristina BergqvistAGCharlie Foundation; Matthew’s Friends; Practice Committee of the Child Neurology Society. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group2018May2132175192Search in Google Scholar
Zhou P, He N, Zhang JW, Lin ZJ, Wang J, Yan LM, et al. Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies. Genes Brain Behav. 2018;17(8):e12456.ZhouPHeNZhangJWLinZJWangJYanLMNovel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies2018178e12456Search in Google Scholar
Archila R, Papazian O. Síndrome de Lennox-Gastaut [Lennox-Gastaut syndrome]. Rev Neurol. 1999;16–31;29(4):346–9. Spanish.ArchilaRPapazianOSíndrome de Lennox-Gastaut [Lennox-Gastaut syndrome]199916–312943469Spanish.Search in Google Scholar
Accardi A, Miller C. Secondary active transport mediated by a prokaryotic homologue of ClC Cl- channels. Nature. 2004:26;427(6977):803–7.AccardiAMillerCSecondary active transport mediated by a prokaryotic homologue of ClC Cl- channels20042642769778037Search in Google Scholar
Guzman RE, Alekov AK, Filippov M, Hegermann J, Fahlke C. Involvement of ClC-3chloride/proton exchangers in controlling glutamatergic synaptic strength incultured hippocampal neurons. Front Cell Neurosci. 2014;23;8:143.GuzmanREAlekovAKFilippovMHegermannJFahlkeCInvolvement of ClC-3chloride/proton exchangers in controlling glutamatergic synaptic strength incultured hippocampal neurons2014238143Search in Google Scholar
Veeramah KR, Johnstone L, Karafet TM, Wolf D, Sprissler R, Salogiannis J, et al. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies. Epilepsia. 2013;54(7):1270–81.VeeramahKRJohnstoneLKarafetTMWolfDSprisslerRSalogiannisJExome sequencing reveals new causal mutations in children with epileptic encephalopathies2013547127081Search in Google Scholar
Fernández-Marmiesse A, Roca I, Díaz-Flores F, Cantarín V, Pérez-Poyato MS, Fontalba A, Laranjeira F, et al. Rare Variants in 48 Genes Account for 42% of Cases of Epilepsy With or Without Neurodevelop-mental Delay in 246 Pediatric Patients. Front Neurosci. 2019:8;13:1135.Fernández-MarmiesseARocaIDíaz-FloresFCantarínVPérez-PoyatoMSFontalbaALaranjeiraFRare Variants in 48 Genes Account for 42% of Cases of Epilepsy With or Without Neurodevelop-mental Delay in 246 Pediatric Patients20198131135Search in Google Scholar
Tassinari CA, Dravet C, Roger J, Cano JP, Gastaut H. Tonic status epilepticus precipitated by intravenous benzodiazepine in five patients with Lennox-Gastaut syndrome. Epilepsia. 1972 Jul;13(3):421–35.TassinariCADravetCRogerJCanoJPGastautHTonic status epilepticus precipitated by intravenous benzodiazepine in five patients with Lennox-Gastaut syndrome1972Jul13342135Search in Google Scholar
Sankar R. GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam. CNS Drugs. 2012;26(3):229–44.SankarRGABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam201226322944Search in Google Scholar
Macdonald RL, Kelly KM. Antiepileptic drug mechanisms of action. Epilepsia. 1995;36l 2:S2–12.MacdonaldRLKellyKMAntiepileptic drug mechanisms of action199536l2S212Search in Google Scholar
Palmer EE, Stuhlmann T, Weinert S, Haan E, Van Esch H, Holvoet M, et al. De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females. Mol Psychiatry. 2018;23(2):222–230.PalmerEEStuhlmannTWeinertSHaanEVan EschHHolvoetMDe novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females2018232222230Search in Google Scholar